Bioharvest Sciences Inc. (BHST): Net Income

Annual figures by period end, from SEC filings.

-$11.13M

Year ended 2025-12-31

2023-12-31 Net Income (USD) 2025-12-31

Period ended	Net Income	Change YoY	Source filing
2025-12-31	-$11.13M	n/m	2026-03-31, From 2025-01-01
2024-12-31	-$12.91M	n/m	2026-03-31, From 2024-01-01
2023-12-31	-$12.56M	n/a	2025-03-31, From 2023-01-01

Net Income at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Net Income	Change YoY
Bioharvest Sciences Inc. (BHST)	2025-12-31	-$11.13M	n/m
Verrica Pharmaceuticals Inc. (VRCA)	2025-12-31	-$17.89M	n/m
Earth Science Tech, Inc. (ETST)	2026-03-31	$3.63M	+11.6%
Sunshine Biopharma Inc. (SBFM)	2025-12-31	-$5.98M	n/m
Lftd Partners Inc. (LIFD)	2025-12-31	-$24.86M	n/m
Zomedica Corp. (ZOMDF)	2025-12-31	-$81.86M	n/m
BGM Group Ltd. (BGM)	2025-09-30	-$19.94M	n/m
Verastem, Inc. (VSTM)	2025-12-31	-$209.47M	n/m
Foghorn Therapeutics Inc. (FHTX)	2025-12-31	-$74.28M	n/m

Compare BHST, VRCA, ETST, SBFM side by side · Screen every company in Pharmaceutical Preparations ↗